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Available online 4 June 2015Mitochondrial DNA has long been posited as a likely target of oxidative damage induced mutation during the
ageing process. Research over the past decades has uncovered the accumulation ofmitochondrial DNAmutations
in association with a mosaic pattern of cells displaying mitochondrial dysfunction in ageing individuals.
Unfortunately, the underlying mechanisms are far less straightforward than originally anticipated. Recent re-
search onmitochondria reveals that these genomes are far less helpless than originally envisioned. Additionally,
new technologies have allowed us to analyze the mutational signatures of many more somatic mitochondrial
DNAmutations, revealing surprising patterns that are inconsistent with a DNA-oxidative damage based hypoth-
esis. In this review, we will discuss these recent observations and new insights into the eccentricities of mito-
chondrial genetics, and their impact on our understanding of mitochondrial mutations and their role in the
ageing process. This article is part of a Special Issue entitled: Mitochondrial Dysfunction in Aging.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
All eukaryotic life on earth is derived from a highly unlikely merger
between at least two independent lifeforms. Genomic evidence from
eukaryotes clearly shows the signature of a merged set of genes of
both archaebacterial (the ancestor of our nuclear genome) and α-
proteobacterial (the ancestor of our mitochondria) origin. Curiously,
mitochondria have retained their own highly reduced genomes
which encode only a tiny subset of the genome of the original α-
proteobacterial gene complement. This necessitates the complicated
import of a large number of proteins just to translate these fewpeptides
[1]. This has led to a large number of hypotheses, seeking to explainwhy
a mitochondrial genome persists, and has not simply ceded complete
control over to the nucleus [2–4].
Despite the estimated 2 billion years of co-evolution, the mitochon-
drial and nuclear genomes appear to have followed drastically different
paths. Unlike the nuclear genome, the animal mitochondrial DNA
(mtDNA) has typically retained the circular and densely coded charac-
ter of the prokaryotic ancestor. Instead of a carefully orchestrated sys-
tem by which all chromosomes are equally copied within cellular
mitosis ormeiosis, mitochondrial DNA is copied and turned over at ran-
dom, to a tempo independent of the cell cycle. Instead of a system of
paired diploidy (or tetraploidy and so on), the mitochondrial DNA is
more akin to a collection of hundreds to thousands of independent
but related bacterial genomes within the cell. These variations from
the nucleus allow for interesting properties and issues that are unique
to the organellar genomes.ndrial Dysfunction in Aging.In order to avoid the overwhelming complexity of eukaryotic mito-
chondrial genome evolution [5], it is necessary here to focus only
on the Metazoa, with emphasis on mammalian mtDNA. Metazoan
mtDNA encodes 11–15 protein coding genes [6,7], the large and small
ribosomal RNAs, the tRNAs necessary to carry out the translationwithin
the mitochondria, and a non-coding control region that harbours se-
quences important for transcription and replication of the mtDNA.
Barring the few rare exceptions, the protein genes maintained on mito-
chondrial DNA are key components of the Oxidative Phosphorylation
(OXPHOS) systems, speciﬁcally mitochondrial respiratory complexes I,
III and IV and the ATP synthase (complex V). Thus, mutations of the
mtDNA typically lead to a dysfunction of the respiratory chain.
It is ﬁrmly established that during ageing, a patchy distribution of
cells within individuals begins to display the hallmarks ofmitochondrial
respiratory chain dysfunction. This pattern has been observed in many
human tissues, and has been associated with the accumulation of circu-
larmtDNAs bearingdeletions ormtDNAswith accumulated pointmuta-
tions. The painstaking accumulation of this data over about the past
25–30 years has been the subject of other recent reviews [8–11].
Mouse models with increased rates of mtDNA mutation [12–14] or
mtDNA deletion mutations [14–16] have also shown phenotypes strik-
ingly similar to ageing. However, there are no reports to date of models
that can decrease the mutation load to test whether lower levels of
mtDNA mutations can slow the onset of ageing phenotypes.
The anticipated source of mtDNA mutations was greatly inﬂuenced
by Harman's free-radical theory of ageing [17,18]. Perhaps inspired by
the pervious comparisons between ionizing radiation exposure and a
hypothesized similarity to “oxygen poisoning” [19], Harman ﬁrst pro-
posed that oxygen radical could be responsible for cellular damage in
the ageing process [17]. By 1972, he had proposed that mitochondria
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agents responsible for the free-radical based ageing [18]. This view
was extended into a “vicious cycle” theory,wherebymutations accumu-
lating over time in the mitochondrial DNA would lead to dysfunctional
OXPHOS components that will go on to leak more Radical Oxygen Spe-
cies (ROS) and induce more mtDNA mutation in a run-away cycle that
leads to cellular impairment [20].
However, recent work that has advanced understanding of mito-
chondrial biology has called into question a number of the assumptions
that underlie this theory. In this review, we will highlight recent re-
search that showsmtDNA is not helpless in the face of constant free rad-
ical assault. We will also highlight recent work that characterizes these
low-level somatic mtDNAmutations, and discuss what these mutation-
al signatures tell us about mtDNAmutations during ageing. And ﬁnally,
we will discuss the forces that guide these mtDNAmutations from rare
and insigniﬁcant cellular occurrences to the dominant forms of mtDNA
within a cell where they may induce the mitochondrial dysfunction
characteristic in ageing animals.
2. mtDNA defences
2.1. DNA physical and spatial defences
One common assertion is that mitochondrial DNA is free of histones,
so “naked” and vulnerable to oxidative DNA damage due to superoxide
radical produced by the nearbyOXPHOS system.Wenowknow thatmi-
tochondrial DNA exists in a compacted DNA–protein complex known as
the mitochondrial nucleoid [21–25]. The dual-role protein TFAM ap-
pears to be a major component of the nucleoid, but research into the
exact composition and the dynamics of the protein components of nu-
cleoids continues [26–28]. Protein-coating of the DNA is expected to
act as a shield against DNA damage and enhance the stability of the
double helix.
Additionally, the mitochondria are more compartmentalized than
commonly appreciated. The OXPHOS complexes, which are the main
sources of the free radicals, have been demonstrated to be tightly se-
questered into cristae with diameters ~20 nm in size [29]. These cristae
are far too small to ﬁt the ~100 nmnucleoids [24,25], appearing to phys-
ically isolate the mtDNA from this site of free radical production. Thus,
mtDNA does not sit, naked and helpless, besides the source of mito-
chondrial free radicals.
2.2. mtDNA repair mechanisms
A second assertion involves the lack of mtDNA repair pathways
withinmitochondria. This assertion likely arises from early experiments
to test for nucleotide excision repair (NER) in mitochondria. Mitochon-
drial extracts were unable to removemost common nucleotide excision
repair substrates, such as thymidine dimers [30], cisplatin intrastrand
crosslinks, complex alkylation damage, and other forms of damage
[31,32], inferring the absence of NER in the mitochondria. However, re-
cent work has revealed that mitochondria can repair many other types
of DNA damage. The most well-studied repair pathway found in mito-
chondria is base excision repair (BER), where the damaged base is
recognized and removed by a speciﬁc glycosylase followed by gap tai-
loring, ﬁlling and ligation of the DNA. Many of the nucleus-targeted
BER pathway proteins have been found to also localize into mitochon-
dria in identical or alternatively processed forms in human cells. Two
subcategories of the pathway are recognized; namely long- and short-
patch BER. In short-patch BER only a few nucleotides are removed
upon damage repair whereas in long-patch BER mostly 5′ blocking
groups are removed, which requires removing longer stretches of
DNA. The enzymes required to carry out short-patch BER have been
found in mitochondria.
The ﬁrst step in base excision repair is the removal of the damaged
base by a speciﬁc DNA glycosylase. Six glycosylases are found inmitochondria, which are specialized in removing different damaged
bases. Due to their distinct catalytic mechanisms, they require different
downstream gap tailoring enzymes. Uracil DNA glycosylase I, which
removes the uracil created by cytosine deamination [33,34], and the ho-
molog of Escherichia coli MutY (MUTYH), which removes adenosine
erroneously incorporated against 8-oxo-deoxyguanosine (8-oxo-dG)
[35,36], leave behind an abasic site. In contrast, the other four
glycosylases also cut the phosphodiester bond. The other glycosylases
are 8-oxoguanine DNA glycosylase 1 (OGG1) and three homologs of
E. coli glycosylases, endonuclease III (NTH1), and two endonuclease
VIII-like proteins (NEIL1 and NEIL2). OGG1 removes 8-oxo-dG and pos-
sibly the ring-open form of guanine (FAPy guanosine) from double
stranded DNA [37,38]. NTH1 has mostly been associated with thymine
glycol removal [39–41], whereas NEIL1 is suggested to repair thymine
glycol, FAPy and 5-hydroxyuracil and have some activity for 8-oxo-dG
removal [42,43] and NEIL2 is involved in removing 5-hydroxyuracil
and other oxidized derivatives of cytosine [44,45]. Interestingly, in
in vitro assays NEIL1 and 2 are found to be most active at so-called
DNA-bubble structures [46], possibly explaining the redundant damage
targets of these oxidative-damage repairing glycosylases [39]. All of
these glycosylases leave behind a non-ligatable ends that need to be fur-
ther processed by gap tailoring enzymes apurinic/apyrimidinic endonu-
clease (APE1) [47] or PNKP [44,48], who have both been found in
mitochondria.
In addition to short-patch repair, long-patch repair activity has been
found in puriﬁed mitochondria from multiple sources such as mouse
liver, kidney and human lymphoblasts [49–51]. Long-patch repair is
suggested to be highly important for mitochondrial functionality, since
it repairs one of the common lesions caused by oxidative damage to
the sugar-phosphate backbone; 5′ deoxyribolactone [52]. In contrast
to BER, DNA Mismatch repair (MMR) focuses on recognizing and
repairing base–basemismatches and small loops.Mitochondrial speciﬁc
MMR activity has been reported from rat mitochondrial lysates and
mitoplasts of human cell lines [53,54] but the main proteins involved
in nuclear MMR have not been found in mitochondria. One candidate
protein with a binding activity towards mismatched DNA, YB-1, local-
izes to mitochondria and its knockdown decreases the MMR activity
in mitochondria [55].
Animal knockout models of these repair enzymes show a range of
phenotypes, from carcinogenesis (in a MUTYH knockout [56]), to
knockouts that develop metabolic syndrome and obesity (OGG1 [57,
58] and NEIL1 [59]). While the metabolic phenotypes are suggestive of
problems with mtDNA, further work is required as the gene products
are thought to function in both the mitochondria and nucleus, making
the elucidation ofmitochondria-speciﬁc phenotypes very difﬁcult. Anal-
ysis of the NEIL1 knockout mice revealed increased levels of DNA dam-
age, and the accumulation of mtDNA molecules bearing deletions, but
no analyses were undertaken to determine if the mice harboured
bona ﬁde mtDNA mutations [59]. And surprisingly, some studies of
knockout of OGG1 [60] or OGG1/MUTYH double knockouts [61] fail to
observe enhanced accumulation of mtDNAmutations. The construction
of knock-in models that disrupt only the mitochondrial or nuclear
activity will be required to resolve these issues.
3. The origins of mtDNA mutations
3.1. The long road from free radical to DNA damage
Much attention has been focused on the putative role of reactive ox-
ygen species inmitochondrial mutagenesis. ROS are thought to bemore
prevalent inmitochondria than the nucleus becausemost of the cellular
ROS are produced by themitochondrial respiratory chain, in the form of
superoxide. However the path from superoxide to DNA mutation is
much more indirect than implied and a complex chain of events is re-
quired to convert superoxide to a potent DNA damage molecule
(Fig. 1). Superoxide is actually quite unreactive with DNA [62], and
Fig. 1. The long road from free radical to mtDNAmutation; a schematic representation of oxidative damage to mitochondrial DNA and its consequences. The main sites of superoxide (O2*−)
production in OXPHOS are complexes I and III. In contrast to complex I, complex III produces superoxides to bothmatrix and intermembrane space. Superoxide can either transform into H2O2
spontaneously or with the help of SOD1 and SOD2. Neither superoxide nor H2O2 can efﬁciently attack DNA but through Fenton chemistry H2O2 can be converted into the highly reactive
hydroxyl radical, OH*. OH* can react with either bases or the sugar-phosphate backbone leading to single-stranded breaks, abasic sites, DNA–DNA intrastrand adducts, DNA–protein crosslinks
and base damage [67]. For example, themain products of guanosine base damage are oxazolone, FAPy-G and 8-oxo-dG.Whereas the highestmeasuredmutagenic potential for 8-oxo-dG is 10%
[136].
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and damage the mtDNA, the superoxide must be converted to H2O2, ei-
ther spontaneously or by superoxide dismutase. H2O2 is able to leave
mitochondria and thus cause damage to the whole cell. However, it is
still an inefﬁcient agent of DNA damage [62], and there are multiple
H2O2 scavengers located to mitochondria to deal with H2O2 [65]. H2O2
can, however, react through Fenton chemistry with transition metals
such as iron and convert to a hydroxyl radical, the most reactive ROS,
whose reactivity is only restrained by diffusion [66]. A hydroxyl radical
is able to react with DNA causing single stranded breaks, abasic sites,
DNA–DNA intrastrand adducts, DNA–protein crosslinks and base dam-
age [67]. Despite the H2O2 scavenging system there is evidence that
mtDNA may be more vulnerable than nuclear DNA to H2O2, showing
higher frequency of H2O2 driven lesions in cell culture systems [68]. In
recent studies, it was found that H2O2 treatment resulted in strand
breaks or abasic sites that are converted to strand breaks [69]. Possibly
suggesting that instead of base modiﬁcations, single stand breaks
would be the main product of oxidative damage. Thus, the relationship
between free radicals andmtDNAmutations is not as straightforward as
often portrayed.
The initial measurements for oxidative damage levels in mtDNA
were found variably different between groups on the same tissue,most-
ly due to technical issues in the measurements [70]. Recently the mea-
surements were repeated and the levels of oxidative lesions in mtDNA
were found to be comparable to nuclear DNA in rat liver [71]. Some ox-
idative lesions such as 8-oxo-dG, FAPy guanosine and 5-hydroxyl cyto-
sinewere found at a higher frequency in nuclear DNA thanmtDNA in rat
liver [72]. The age of the tested animals did not have an effect on theamounts of DNA lesions in rat liver [71], suggesting that the damage
does not accumulate, but was turned over or repaired.
If DNA damage is induced, we have still not moved on to amutation.
Many forms of DNA damage will induce a replication blockage instead
of propagating a novel mutation [73]. One can imagine that rare replica-
tion blockages within themulti-copymtDNA systemwould be a prefer-
able outcome to mutations, which can then be propagated through the
system. In vitro studies with human pol γ have revealed that replication
is simply blocked upon encountering an 8-oxo-dG adduct in most in-
stances [74]. When it did copy through, human and Xenopus pol γ usu-
ally inserted the appropriate C across from the adduct [74,75]. While
mutations can also be introduced by incorporating damaged nucleo-
tides, such as 8-oxo-dGTP across from and A during replication [73],
pol γ has been found to strongly discriminate against the damaged
base during in vitro replication assays [74]. Thus it appears that the mi-
tochondrial polymerase itself also provides efﬁcient protection against
damage-induced mutagenesis.
Consistent with this multi-step defence against oxidative damage,
recent work is beginning to demonstrate that in vivo levels of oxidative
damage to mtDNAmay not be of great consequence to animals. Studies
in mice found no increase in mutation frequency of mtDNA mutation
when both OGG1 and MUTYH are knocked out in mice [61], while the
nucleus shows the hallmark increase in G to T mutagenesis in OGG1
knockout mice [76]. More surprisingly, ﬂy models with disrupted
OGG1 or SOD2 + OGG1 double knockouts also failed to reveal an in-
crease in mitochondrial mutagenesis due to 8-oxo-dG damage [60].
These observations at ﬁrst seem to contradict reports that over-
expression of superoxide dismutase [77] or the ectopic expression of a
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mice [78–80]. However, these studies may be telling us that mitochon-
drial components other thanmtDNAare actually the targets of oxidative
damage to the cell.3.2. Mutational signatures of DNA damage
The discussion of mutations, SNPs or alleles in the literature often
tends to name mutations relative to only one strand of the DNA, either
the strand appearing in their reference sequence, or the sense strand
of the gene or element under study. However, it is often not immediate-
ly possible to tell which strand the mutation arose on (C to T on the
sense strand or G to A on the antisense). To not imply the causative
base in the mutation it is common to refer to the basepair, limiting the
mutational proﬁle to two types of transition mutations (C:G pairs mu-
tating to T:A, or T:A pairs to C:G), and four classes of transversionmuta-
tions (C:G to A:T, C:G to G:C, T:A to A:T and T:A to G:C).
Unfortunately, themost commonmutation inmtDNA (C:G to T:A) is
not diagnostic of the source of the mutation, as it may arise by various
mechanisms. Hydrolytic deamination of cysteine is quite prevalent in
the cell, and the resulting uracil is used as a template for an A addition
on the opposing strand [81]. An identical mutational signature can
also be induced by oxidative deamination of the cysteine, to create 5-
hydroxyuracil, which also serves as the template of A [82]. These lesions
have been demonstrated to be miscopied by pol γ, both in vitro and
in vivo [83]. Additionally, oxidative deamination of guanine on the
other strand to xanthine or oxanine can mispair with T when copied
by other polymerases [84]. However, the same mutational proﬁle can
also occur due to replication errors. One study of pol γ errors that
arose during in vitro replication showed that more than 84% of the ob-
servedmutations were (C:G to T:A) transitions despite G and C only oc-
cupying 28% of the sites in the assayed region [83]. Unfortunately these
numbers cannot be seen as the deﬁnitive in vitro mutation proﬁle, as
the experimental design was such that only high-frequency mutations
had their identity determined by sequencing [83].
The signature of oxidative damage is therefore sought by the effect
of the rate of transversions; particularly the rate of G:C to T:A
transversions via an 8-oxo-dG lesion. These lesions quite readily occur
in DNA, and can even occur during DNA exposure to phenol, such as
during DNA extraction [85]. Due to the prevalence of this lesion, and
the unusual transversion bias that it can leave, the G:C to T:A is the sig-
nature of oxidative damage most sought during mutational studies.3.3. Replication errors
Themutagenic capacity of DNA replication is often overlookedwhen
discussing mtDNA mutations. The small, multi-copy nature of the
mtDNA means that each base is replicated more often than its nuclear
counterparts during the life of the organism, increasing the likelihood
that a given site will eventually be mis-copied. After starting life as an
oocyte containing only ~2 × 105 mtDNAs (~3 × 109 bp), an adult
human is estimated to contain about 4 × 1013 nucleated cells [86].
With about 104 mtDNAs per cell, this represents ~7 × 1020 bp of
humanmtDNA in the body, providing ample opportunity for replication
errors during development.
Fortunately, in vitro assays of the error rate of pol γA revealed amu-
tation rate of 5.6 × 10−7 mutations/bp/doubling [83], showing that the
enzyme is actually quite accurate compared to other DNA polymerases.
For comparison, Pfu on mitochondrial template in a similar assay gave
an error rate of 6.5 × 10−7 mutations/bp/doubling [87]. Yet even with
this impressively accurate replication system, a substantial number of
mutations are expected, and once an error is introduced, the relaxed
replication system of mtDNA can spread that mutation, even in termi-
nally differentiated cells [88].3.4. The extent of human heteroplasmy
Recently, next-generation sequencing has been applied to study so-
matic mtDNA mutations in humans [89–94]. As well, deletion muta-
tions, where a circular mtDNA molecule lacking large stretches of
sequence is maintained within the mtDNA pool, have been identiﬁed
by next-generation sequencing [93] and digital PCR-based methods
[95]. As the sequencing method itself is known to be quite error-
prone, detailed error-checking strategies have been develop to attempt
to counteract these biases [96,97]. Additionally, nuclear inserts of mito-
chondrial sequence (NUMTs [98]) are especially problematic in these
sorts of short-read analyses, as it is very difﬁcult to obtain mtDNA that
is completely free of small nuclearDNA fragments [99]. Various process-
es have been employed to check for known NUMTs [91,100], but this
problem is very difﬁcult to overcome in silico due to the polymorphic
state of NUMTS in humans [101].
Analysis of themutational bias appears to further erode the possibility
that oxidative damage is the major contributor to mtDNA mutations. An
ultrasensitive next-generation sequencingmethod that essentially gener-
ates consensus sequences by tracking themultiple reads of the sameDNA
fragments has been developed [102] and applied to the study of mtDNA
mutagenesis during ageing [89]. Samples obtained from very young
brain autopsies revealed mutation loads at ~4 × 10−6 mutations/bp, but
increase to ~2 × 10−5 mutations/bp from individuals N75 years of age.
The mutation pattern revealed a strong bias towards the two forms of
transition mutations (C:G→ T:A and T:A→ C:G). T:A–C:G mutations are
not a predicted damage induced mutation, and there was no evidence
of signiﬁcant G:C→ T:A transversion mutations predicted by 8-oxo-dG
damage, implying replication transition errors as the source of the muta-
tions. Additionally, the mutational bias did not shift towards damage sig-
natures such as G:C→ T:A transversions with age, implying that acquired
oxidative-damage induced mutations were not accumulating over the
lifetime.
An unusual strand bias in vertebrate mitochondrial DNA has long
been noted. Mammalian mtDNAs have long been known to have a mis-
balance of nucleotides on the two strand of the mtDNA, leading to their
property being separable into a heavy and a light strand on alkaline ce-
sium chloride gradients [103]. The reference strand for the humanmito-
chondrial DNA (the light strand) encodes ~31% C, but only ~13% G.
Recent analysis of the somaticmutational spectrum in human brains re-
vealed a mutational bias that would explain such a pattern. Throughout
the coding regions, the mutational bias obtained from young human
brain samples revealed that C:G to T:A mutations were more likely to
occur if the light strand encoded a G at the mutated position [89]. In
the samples from aged individuals, this pattern became even more
prevalent, and was accompanied by a bias of T:A to C:G mutations
that were more likely if the T was found on the light strand, mirroring
the preference of the light strand for A (~31%) over T (~25%). However,
this strand asymmetry bias was absent in the mtDNA's control region.
This pattern was also reported in a subsequent next-generation se-
quencing study, also in the human brain [93], and had previously been
shown on a small-fragment analysis of a human lung epitheliummuta-
tions. In this study, 5 of the 7 G sites underwent this transitionmutation
but none of the 13 C sites were mutated, and light-strand T bases was
mutated 3 times more than light-strands A bases [83]. At present, the
cause of this mutational bias is speculative, but the similarity to the
bias observed over evolutionary timescales has been noted [89]. This
may link to process to themechanism ofmtDNA replication, as inverted
control region and replication elementswithin someﬁsh lead to a rever-
sal of the strand bias [104,105].
It appears that this strand-speciﬁc mutational bias against the mi-
nority nucleotides within the mtDNA strand has important functional
consequences. The subsequent study of human brain noted that this
strand bias produced mutations that were predicted to have a higher
probability of being detrimental to the encoded protein [93]. Such a pat-
tern makes sense, as bases conserved in the face of a strong mutational
1358 J.H.K. Kauppila, J.B. Stewart / Biochimica et Biophysica Acta 1847 (2015) 1354–1361pressure are likely to be the bases preserved by purifying selection on
the resulting gene product. Additionally, these mutations will also be
more likely to reoccur within an individual, and in different individuals,
providing a recurring set of mutations that are likely to cause harm, if
they can clonally expand to sufﬁcient levels within the cell.
3.5. From mutation to malfunction
These new results show a surprising level ofmtDNAheteroplasmy in
humans, with some authors conceding that mtDNA heteroplasmy is
universal in us [92]. While many of thesemutations are probably harm-
less, some would have the potential lead to functionally deﬁcient mito-
chondria, if the mutation can become the dominant allele within that
cell. The pathogenic nature of mtDNA mutations in the human colon
have long been analyzed and studied, where the biology of the colonic
crypts allows for the clonal expansion and preservation of cells reveal-
ing mitochondrial deﬁciency [106,107]. These studies clearly demon-
strate that mutations leading to deleterious consequence are present
within us, and with sufﬁcient time and misfortunate ampliﬁcation of
the deleterious alleles by the relaxed replication system, a deleterious
allele can come to dominate in the cell and lead to mitochondrial dys-
function in vital organ systems.
An early modelling study clearly showed that the mutations would
have to have developed early in life to have the time to reach dominat-
ing levelswithin the cell [108]. In agreementwith this prediction, recent
work in the human colonic crypts that reveal an increase in the number
of dysfunctional cell clusters with age, but in the absence of an increase
in the total mutational burden in the tissue. This argues that the prolif-
eration of pre-existingmutations from early in life, not the introduction
of new mutations, leads to the observed mitochondrial dysfunction
[109]. One recent study with deletion mutations of mtDNA also found
that the diversity of these molecules did not appear to change in sam-
ples from people of different ages [95], implying that these deletions
are also generated predominantly in early life and require time to ex-
pand to become prevalent in the tissues. However, this interpretation
of the deletion data has met with some controversy [110,111].
Rodents have long been the mammalian laboratory models of
choice, so it was natural that ageing research would also utilize mice.
The ageing mouse model was supported by a very early observation of
the increase in deletion and insertion mutations in mice over their
lifespan [112], similar to observations in humans. Unsurprisingly,
there is not perfect concordance between natural ageing in mice and
humans. Humans, with ~40× longer lifespan, will allow more time for
clonal expansion and the resulting respiratory chain dysfunction.
Modelling has shown that this may limit the utility of some short-
lived species in their use to study the clonal expansion cycle of mtDNA
mutation, as there is insufﬁcient time for a given spontaneousmutation
to reach high relative levels and lead to mitochondrial dysfunction
[113]. These models are supported by recent work showing much less
clonal expansion in the colonic crypts of aged mice in comparison to
aged humans [114]. However, using mice with an approximately 10×
increased rate of mtDNAmutation [115] appeared to speed up the pro-
cess, leading to a better approximation of the cellular levels of mito-
chondrial dysfunction observed in the colonic crypts of humans [116].
These observations suggest that clonal expansion of the deleteriousmu-
tation to levels that can compromisemitochondrial function is critical in
this process. Mutations arising late in life may simply have insufﬁcient
time to reach to the levels necessary to compromise the cell. Conversely,
the earlier in life a mutation occurs, the more chance it has to clonally
expand and contribute to cellular pathology.
3.6. Inherited mtDNA mutations
We typically assume that the somatic mtDNAmutations are speciﬁc
to that individual, but the recent data analysis has clearly shown that
mtDNA mutations can be transmitted between generations [90,109].Indeed, most cases of mtDNA mutation related mitochondrial disease
are cases where a healthy mother with non-pathogenic levels of a mu-
tant allele gives rise to a child that crosses thatmutation's heteroplasmy
threshold and leads to disease [117]. In mice with increased rates of
error-pronemitochondrial replication, maternal transmission of mutat-
ed mtDNAs has been shown to lead to decreased general health and fe-
cundity [115]. Additionally, these transmitted mutations alone can
reduce the lifespan of offspring with wildtype nuclear DNA [118].
Transmitted mtDNA mutations are, however, subject to some form
of a female germline ﬁltering. Work in mice has shown that the female
germline can eliminate speciﬁc mtDNAmutations, especially in protein
coding genes [119,120]. Work in humans has also identiﬁed that muta-
tions that originated in the very early embryo or were derived from the
oocyte also show a trend towards decreased pathogenic potential [109].
This property of mtDNA purifying selection in the germline has also
been identiﬁed in Drosophila [121,122], implying a broad evolutionary
distribution within animals. Thus, subsets of the mutant alleles in
mtDNA appear to be eliminated from the germline, which would have
beneﬁcial consequences on the integrity of the offspring. However,
some deleterious alleles are able to pass by this quality control system
(for example in mice, see [120,123–125]). The mitochondrial germline
transmission bottleneck [126] may allow for the more rapid expansion
of the allele in the soma of the developing embryo, and the mutation
would thus have a head start in their progress towards mitochondrial
dysfunction in the ageing process.
4. Somatic mtDNA selection and drift
4.1. Seeking somatic selection of mtDNAs
It is important to stress that in nearly all instances, the clonal expan-
sion of mtDNA mutations is best described by a neutral drift model
[108], in the absence of selection for or against somatically acquired
mtDNA mutations [107]. However, exceptions have been reported.
Until recently, these have been conﬁned to mitochondrial mutation
levels in the blood patients with the mitochondrial disorder MELAS
[127]. In the mtDNA mutator mice, the control region of the mice was
found to reveal a lowered mutation load in comparison to the other,
coding regions of the genome [12,128]. A subsequent study of the
light strand origin of replication inmtDNAmutatormice found a similar
pattern at this second replication origin, and complimentary in vitro
replication assays revealed that alterations in this sequence lead to de-
creased replication efﬁciency [129]. Thus, it appears that purifying se-
lection against mutations that decrease the replication efﬁciency of
the mtDNA molecule is at work within the somatic tissues.
Next-generation sequencing efforts have identiﬁed other mutations
with unusual behaviours in the control region. Recurring variants in the
mitochondrial control region have been identiﬁed, and some appear to
preferentially clonally-expand in different tissues of individuals with
age [130,131]. Particularly, the position 16093 appears to confer odd
segregation patterns in individuals. Two studies found that the 16093
positionwas heteroplasmic in other tissues, but remained homoplasmic
for C in the blood [90,132]. Two additional studies found that the allele
had a tissue-speciﬁc elevation in relative levels. The 16093T allele was
strongly biased in the skeletalmuscle, while the 16093C allele remained
dominant in the other tissues sampled from the same individual [130,
131]. Further investigation of this site and any others is needed, but if
such tissue-speciﬁc selection is at work, deleterious mutations that
occur on the same molecule as such a mutation may be drawn to high
levels via a hitch-hiking effect with these otherwise harmless alleles.
4.2. Selection in tumour mtDNA
Somatic level purifying selection of mtDNA mutations has also been
reported in tumour cells. One study into colorectal cancers showed that
while pre-cancerous adenomas had similar mtDNAmutation frequencies
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levels of overall mtDNA mutations than the control tissues from the
same individual [133]. Though clonal propagation of a single cell may ex-
plain a decrease in the mutations present in the sample, the fact that this
trend was isolated to tumours, and not present in pre-cancerous adeno-
mas, implied a selective loss of mutations only in the cancerous samples
[133]. The largest study of cancer mtDNA mutations looked at 1645 tu-
mour samples and identiﬁed 1907 mutations speciﬁc to the tumour
cells [134] Intriguingly, the mutation bias across all of the identiﬁed mu-
tations in all tumour types was quite similar, and reﬂected a transition
bias that again implied replicative errors and not DNA damage as the
source of the mtDNAmutations [134]. Most of these mutations appeared
to be segregating under a neutral drift model, except for protein-
truncatingmutations. Thesemutations,while present at the expected fre-
quency, appeared to be limited in the relative levels that these mutations
were able to obtain. A similar bias against protein-truncating mutations
was previously observed in a mouse with a frameshift mutation in the
mt-nad6 gene [120]. The study also reportedno anticodon-disruptingmu-
tations within the tRNA genes, despite the expectation of observing ~8
such mutations in a study of this size. While these results conﬂict with
claims of positive selection in previous next-generation sequencing stud-
ies of tumourmtDNAmutations [135], this study had amuch larger set of
mutations to use in their statistical analysis, and they applied a more
stringent and evolutionarily sound null hypotheses when testing for se-
lection within the pool of observed mutations.
4.3. Selecting for mtDNA mutations
Curiously, one of the above-mentioned studies of normal human tis-
sues reported an excess of tissue-speciﬁc heteroplasmic mutations
within liver samples. Analysis of these mutations revealed a liver-
speciﬁc excess of non-synonymous heteroplasmic changes [131]. The
observation of excess non-synonymous mutations is the hallmark of
positive selection — the favouring of the observed amino-acid changes
or linked alleles on the same mtDNA. Such a surprising ﬁnding will
need further validation in subsequent studies. Intriguingly, during a
next-generation sequencing analysis of mtDNA mutator mice, a single
mouse showed three heteroplasmicmutations in the liver, representing
more than 60% of the obtained reads, while all other mutations in the
study were observed in less than 30% of the reads [99]. The three muta-
tions were most likely linked, and represented a synonymous mutation
in mt-nad2 (c4135T), an S–L mutation in mt-nad6 (g14042A), and a
control region mutation near the ETAS2 conserved sequence block
(c15579T).
5. Summary
Our expanded understanding of mitochondrial biology has led to a
reassessment of the mitochondrial genome. Far from being a genome
helpless to stave of the assault of oxidative damage, the mitochondria
appear to have packaged [24,25] and sequestered the mtDNA away
from the sites of active radical oxygen production [29]. Research con-
tinues to increase the catalogue of repair enzymes that are targeted to
the mitochondria to deal with potentially mutagenic base damage
[68], and the mitochondrial DNA polymerase itself appears to be highly
accurate and may be able to suppress mutations arising from oxidative
damage [74,83]. The application of next-generation sequencing to
the study of mtDNA mutations has revealed a mutation bias of both
C:G→ T:A and T:A→ C:G transitions; a mutational signature more con-
sistent with replication errors than oxidative DNA damage inducedmu-
tation [60,89,134].
The mtDNA that leads to age-related mitochondrial dysfunction ap-
pears to have arisen quite early in the life of the organism, and in the
majority of cases, slowly underwent neutral drift until reaching high
levels and revealing their pathogenic nature [107–109]. These mutation
may have occurred after the germline purifying selection has acted,thereby avoiding a “selective sieve” that may have eliminated them
[119,121,122], but then have a longer journey from the single novelmu-
tation to the predominant allele in the cell or cells. Or the mutations
were maternally transmitted, having properties that hid them from
the germline selection, but gave them a substantial head start by segre-
gating them into a larger number of developing cell lineages, and poten-
tially boosting their relative numbers in the mitochondrial germline
bottleneck.
Intriguing, but rare mutations that appear to confer a replicative ad-
vantage may also complicate and exacerbate the ageing process if they
carry with them a linked, deleterious allele [130,131]. And despite the
emerging ﬁelds of mitochondrial quality control systems, themtDNA it-
self appears to not beneﬁt from such systems, and the pathogenicmuta-
tions appear to, in the soma, act as though they are neutral until they
cross their speciﬁc heteroplasmic threshold and lead to mitochondrial
dysfunction [109,116]. The soma does appear to be able to select against
mutations that hinder mtDNA replication [129], or protein-truncating
frameshift mutations (at least in one mouse model [120] and in
human tumours [134]). While hints of alleles that confer positive selec-
tion to somatic mtDNAs have been published [131,135], these observa-
tions are new, novel, and in need of further study and veriﬁcation.While
it is often difﬁcult for us to accept that our cellular systems are so inﬂu-
ence and hindered by stochastic errors, it would be evenmore frighten-
ing to consider deleterious mtDNA mutations that are at a selective
advantage within our somatic cells driving us more quickly through
the ageing process.
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